U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
132271132271Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability.RecruitingNo Results AvailableMitochondrial Diseases|Diagnosis|DNA MutationsGenetic: mitochondrial DNA mutations diagnosishttps://ClinicalTrials.gov/show/NCT00831948
132272132272Use of Conversation and Acoustic Signals in Measuring Depression SeverityCompletedNo Results AvailableDepressionhttps://ClinicalTrials.gov/show/NCT00831935
132273132273Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: masitinib (AB1010)|Drug: masitinib (AB1010)https://ClinicalTrials.gov/show/NCT00831922
132274132274Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLINCompletedNo Results AvailableNSCLChttps://ClinicalTrials.gov/show/NCT00831909
132275132275Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological MalignanciesCompletedNo Results AvailableAdvanced Solid TumorsBiological: TAK-701https://ClinicalTrials.gov/show/NCT00831896
132276132276Partner-Specific HIV Risk Reduction Intervention for Drug-Using AdolescentsCompletedNo Results AvailableSexually Transmitted Diseases|Substance-Related DisordersBehavioral: Partner-Specific IMB-based HIV risk reduction intervention|Behavioral: Healthy Lifestylehttps://ClinicalTrials.gov/show/NCT00831883
132277132277EndoSure Sensor for Long-term Follow-up After Endovascular AAA RepairEnrolling by invitationNo Results AvailableAortic Aneurysm, Abdominalhttps://ClinicalTrials.gov/show/NCT00831870
132278132278VEGF Imaging in Renal Cell CarcinomaCompletedNo Results AvailableRenal Cell CarcinomaOther: 89Zr-Bevacizumab PET-scanhttps://ClinicalTrials.gov/show/NCT00831857
132279132279Cixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsCompletedHas ResultsAdult Rhabdomyosarcoma|Adult Synovial Sarcoma|Childhood Hepatoblastoma|Childhood Synovial Sarcoma|Previously Treated Childhood Rhabdomyosarcoma|Recurrent Adrenocortical Carcinoma|Recurrent Adult Soft Tissue Sarcoma|Recurrent Childhood Liver Cancer|RecurreBiological: cixutumumab|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00831844
132280132280Can Safety Planning Improve Perinatal Outcomes Among Pregnant Women Exposed to Intimate Partner Violence?WithdrawnNo Results AvailablePerinatal OutcomesBehavioral: Safety planninghttps://ClinicalTrials.gov/show/NCT00831831
132281132281Effects of Breastfeeding on Maternal Plasma Ghrelin and Peptide Tyrosine Tyrosine (PYY) LevelsCompletedNo Results AvailableBreastfeedinghttps://ClinicalTrials.gov/show/NCT00831818
132282132282Screening of Psycho-cognitive Troubles in Elderly PatientsCompletedNo Results AvailablePsycho-cognitive Troubleshttps://ClinicalTrials.gov/show/NCT00831805
132283132283TKI258 in Castrate Resistant Prostate CancerActive, not recruitingNo Results AvailableProstate CancerDrug: TK1258https://ClinicalTrials.gov/show/NCT00831792
132284132284Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 DiabetesCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Dapagliflozin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00831779
132285132285Phase 1/2 Study of Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)Active, not recruitingNo Results AvailableMyelodysplastic Syndrome|Acute Myeloid LeukemiaDrug: Idarubicin|Drug: Cytarabine|Drug: Lenalidomide (Revlimid®)https://ClinicalTrials.gov/show/NCT00831766
132286132286Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian InfantsCompletedHas ResultsDiphtheria|Tetanus|Pertussis|Haemophilus Influenzae Type b|Hepatitis BBiological: DTaP IPV HB PRP~T vaccine|Biological: DTaP-HB-IPV and Haemophilus influenzae type bhttps://ClinicalTrials.gov/show/NCT00831753
132287132287ACT NoW: Assessing the Effectiveness of Communication Therapy in the North WestCompletedNo Results AvailableStrokeOther: Speech and Language Therapy (SLT)|Other: Attention Controlhttps://ClinicalTrials.gov/show/NCT00831740
132288132288The Role of Affect Regulation and Self-presentation in the Expressive Writing InterventionActive, not recruitingNo Results AvailablePosttraumatic Stress DisordersBehavioral: Expressive Writing|Behavioral: Controlhttps://ClinicalTrials.gov/show/NCT00831727
132289132289Xarelto for VTE Prophylaxis After Hip or Knee ArthroplastyCompletedNo Results AvailableVenous ThromboembolismDrug: Rivaroxaban (Xarelto, BAY59-7939)|Drug: Standard care treatment for VTE prophylaxishttps://ClinicalTrials.gov/show/NCT00831714
132290132290Medical Expulsive Therapy of Single Distal Ureteral StonesCompletedHas ResultsUreteral CalculiDrug: Tamsulosin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00831701
132291132291Efficacy of Local Overpressure Treatment for Meniere's DiseaseCompletedNo Results AvailableMeniere's DiseaseDevice: Meniett(C) device by MedTronic|Device: placebo treatmenthttps://ClinicalTrials.gov/show/NCT00831688
132292132292Study of Safety and Immunogenicity of Fluzone® in Healthy ChildrenCompletedHas ResultsInfluenzaBiological: Influenza Vaccine 2004-2005 Paediatric Formulation|Biological: Influenza Vaccine 2004-2005 Paediatric Formulationhttps://ClinicalTrials.gov/show/NCT00831675
132293132293The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)CompletedNo Results AvailableDry Eye DiseaseDrug: Diquafosol tetrasodium ophthalmic solution, 2%|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00831662
132294132294A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201TerminatedNo Results AvailableRheumatoid ArthritisDrug: TYSABRI (natalizumab)https://ClinicalTrials.gov/show/NCT00831649
132295132295A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian CancerCompletedNo Results AvailableOvarian CancerDrug: CP-4055|Drug: CP-4055https://ClinicalTrials.gov/show/NCT00831636
132296132296Study of Hypofractionated Proton Beam Radiation Therapy for Prostate CancerRecruitingNo Results AvailableProstate CancerRadiation: Proton Radiation|Radiation: Protonhttps://ClinicalTrials.gov/show/NCT00831623
132297132297Post-bariatric Abdominoplasty: Skin Sensation EvaluationCompletedNo Results AvailableObesity|HypesthesiaProcedure: Bariatric surgery (Roux-en-Y Gastric Bypass) + Post-bariatric abdominoplasty.|Procedure: Roux-en-Y gastric bypass (bariatric surgery) + Post-bariatric abdominoplasty (without flap undermining)https://ClinicalTrials.gov/show/NCT00831610
132298132298Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaActive, not recruitingNo Results AvailableDiffuse Large B-Cell LymphomaDrug: bendamustine|Drug: rituximabhttps://ClinicalTrials.gov/show/NCT00831597
132299132299Prospective Analysis of Hypersensitivity Reactions to OxaliplatinActive, not recruitingNo Results AvailableColorectal Cancer|Esophageal Cancer|Gastric Cancer|Small Bowel Cancer|Pancreatic Cancerhttps://ClinicalTrials.gov/show/NCT00831571
132300132300Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)CompletedNo Results AvailableMetastases of Central Nervous System|Melanoma|Breast Neoplasm|Carcinoma, Non-Small-Cell LungDrug: Temozolomidehttps://ClinicalTrials.gov/show/NCT00831545

* Görseller ve İçerik tekif hakkına sahip olabilir